B
Power Law company profile
BenevolentAI
Biotech & Life Sciences · London, United Kingdom · Founded 2013 Unicorn
Revenue
$6.9M
Latest reported FY
Global footprint
Where BenevolentAI has talent and traffic
AI talent share
27.3%
of workforce is AI talent
(18 of 66 staff)
(18 of 66 staff)
Core AI69.09%
Other AI1218.18%
Non-AI workforce4872.73%
Web traffic by country
14K
monthly visits
across markets
across markets
🇬🇧 United Kingdom27.1%
🇺🇸 United States25.7%
🇨🇦 Canada14.3%
🇮🇳 India14.3%
🇸🇦 Saudi Arabia5.7%
Patent intelligence
$4M patent portfolio · 4 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$4M
16.1× smaller than top peer AbCellera Biologics ($63M)
4 active patent families
Where BenevolentAI innovates
DiseasePharmacologyNeuro-degenerative diseasePharmaceutical SubstancesPharmaceutical medicine
Below peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
BenevolentAI on the five Patsnap quality dimensions
BenevolentAI in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where BenevolentAI concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across BenevolentAI and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee BenevolentAI on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.